F694 in Louisiana. Pick another state for the same tag.
Against expectation — 2025
Louisiana cites F694 less often than its own record predicts
Versus expected share0.59×
0.59 times the national share — cited less often here than elsewhere.
Share of Louisiana citations0.19%
Of every deficiency written in Louisiana in 2025, this is the portion that was F694.
Louisiana0.19%
National0.32%
Share of all citations that were F694.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Louisiana surveyors wrote
F694 findings written in Louisiana, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedFebruary 11, 2026
Based on observation, interviews, and record review the facility failed to administer parenteral fluids consistent with professional standards of practice for 1 of 1 (#5) resident reviewed for intravenous antibiotic therapy. The facility failed to administer antibiotic therapy at the prescribed rate for Resident #5.Review of the facility's policy dated 10/2016, titled Administration of Fluids/Medications via a Central Line Catheter revealed in part, the following:11. Start the infusion at the prescribed rate. Review of Resident #5's Clinical Record revealed he was admitted to the facility on [DATE]. Review of Resident #5's current Physician Orders revealed an order for Cefepime Intravenous Solution 2 grams per 100 milliliters. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction